Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.
In isolated rabbit lungs standardized amounts of edema were induced. Stimulation with the Ca ionophore A23187, leukotriene C4, Pseudomonas aeruginosa cytotoxin and human serum (activated complement) all resulted in protein leakage into the alveolar space with no change in the total phospholipid content. The pressure-volume characteristics of the lungs and the characteristics of the lavage surfactant (Wilhelmy balance) were markedly altered, correlating to the lavage protein content. The surfactant alterations were reproduced by addition of perfusion fluid protein to control surfactant in vitro. All changes were far less expressed or even missing in isolated lungs developing the same amount of edema due to omittance of proteins from the perfusion liquid. Different proteins added to control surfactant in the Wilhelmy balance showed a marked rank order of potency in interfering with surfactant function: immunoglobulins G and M and elastin less than albumin less than fibrinogen less than fibrin monomers. The fibrin monomer effect was reproduced by addition of thrombin to a surfactant fibrinogen mixture and was partly reversed by subsequent incubation with plasmin. In conclusion, high-permeability edema induced by different means results in alterations of lung mechanics and surface activity of lavaged surfactant, presumably due to protein surfactant interaction. Among different proteins, fibrin monomers are especially effective in interfering with surfactant function.
D000818:Animals; D001798:Blood Proteins / Q000494:pharmacology*; D002463:Cell Membrane Permeability; D004549:Elastin / Q000494:pharmacology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000494:pharmacology*; D005340:Fibrinogen / Q000494:pharmacology; D007074:Immunoglobulin G / Q000494:pharmacology; D007075:Immunoglobulin M / Q000494:pharmacology; D008168:Lung / Q000378:metabolism / Q000503:physiopathology; D008176:Lung Volume Measurements; D008297:Male; D010477:Perfusion; D010743:Phospholipids / Q000378:metabolism; D011312:Pressure; D011654:Pulmonary Edema / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D011663:Pulmonary Surfactants / Q000378:metabolism / Q000502:physiology*; D011817:Rabbits; D012709:Serum Albumin / Q000494:pharmacology; D013500:Surface Tension
D001798:Blood Proteins; D005338:Fibrin Fibrinogen Degradation Products; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010743:Phospholipids; D011663:Pulmonary Surfactants; D012709:Serum Albumin; C011468:fibrinmonomer; D005340:Fibrinogen; D004549:Elastin